Home / News / Biovation unveils BioArmour Blood Pressure Cuff Shield

Biovation unveils BioArmour Blood Pressure Cuff Shield

28 Mar '15

2 min read

Biovation has launched the BioArmour Blood Pressure Cuff Shield (BPCS) to lessen the spread of infectious pathogens from blood pressure cuffs.

One of the first in a suite of infection and pathogen control products from Biovation, BioArmour offers a multi-use barrier for prevention of hospital acquired infections (HAIs). The BPCS has been designed, tested, and validated over a two-year cycle, and is now available in European, Canadian, and all non-US markets.

The easy-to-use BioArmour BPCS is a disposable antimicrobial hygienic barrier that attaches to the blood pressure cuff to prevent direct contact of the cuff with the patient’s skin. The latex-free shield material is composed of a sustainable biopolymer impregnated with antimicrobial and antifungal agents to mitigate the propagation of a wide spectrum of pathogens in controlled release fashion, Biovation said in a statement.

In lab testing, the BioArmour BPCS has been shown to kill up to 99.99 per cent of tested microorganisms. The BPCS is manufactured with green technology and a sustainable biopolymer, with an industry-leading 74 per cent biocontent. The cost-effective system requires no staff maintenance or disinfection between patients and is targeted for in-patient, physician offices, hospitals, nursing home facilities, and emergency medical services.

Biovation CEO Kerem Durdag said, “Our BPCS is a proactive measure that helps hospitals and healthcare facilities support their infectious disease reduction and control efforts. It is an easy-to-use and cost-effective tool that contributes to patient health and safety. The proprietary manufacturing technology we have employed sets a benchmark for our products in our pipeline.”

Sciessent, a leading provider of customized antimicrobial solutions, partnered with Biovation to develop the antimicrobial technology.

Lise Moloney, director of business development – healthcare, Sciessent said, “The BPCS infuses our world-class antimicrobial solutions into Biovation’s biopolymer fibres to result in a safe, non-leaching product with broad-spectrum efficacy.”

Biovation is a technology design and manufacturing company that produces advanced, non-woven fibre products with integrated antimicrobial properties for packaging, healthcare, specialty niche roll goods and wipes products and other specialty advanced material end products. (GK)

Fibre2fashion News Desk - India